<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34233951</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>601</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Genome-encoded cytoplasmic double-stranded RNAs, found in <i>C9ORF72</i> ALS-FTD brain, propagate neuronal loss.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eaaz4699</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.aaz4699</ELocationID><Abstract><AbstractText>Triggers of innate immune signaling in the CNS of patients with amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD) remain elusive. We report the presence of cytoplasmic double-stranded RNA (cdsRNA), an established trigger of innate immunity, in ALS-FTD brains carrying <i>C9ORF72</i> intronic hexanucleotide expansions that included genomically encoded expansions of the G<sub>4</sub>C<sub>2</sub> repeat sequences. The presence of cdsRNA in human brains was coincident with cytoplasmic TAR DNA binding protein 43 (TDP-43) inclusions, a pathologic hallmark of ALS/FTD. Introducing cdsRNA into cultured human neural cells induced type I interferon (IFN-I) signaling and death that was rescued by FDA-approved JAK inhibitors. In mice, genomically encoded dsRNAs expressed exclusively in a neuronal class induced IFN-I and death in connected neurons non-cell-autonomously. Our findings establish that genomically encoded cdsRNAs trigger sterile, viral-mimetic IFN-I induction and propagated death within neural circuits and may drive neuroinflammation and neurodegeneration in patients with ALS/FTD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2708-5791</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahin</LastName><ForeName>Asli</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4706-3071</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrank</LastName><ForeName>Benjamin R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0001-8138-4250</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Lawati</LastName><ForeName>Hawra</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5228-1025</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costantino</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8807-2305</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benz</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fard</LastName><ForeName>Darian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4413-1833</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>Alefiya D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-2660-6927</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, Endicott College, Beverly, MA 01915, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Luxiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Alexis C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-3522-623X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6246-9520</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9321-7908</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cudkowicz</LastName><ForeName>Merit</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7075-1681</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frosch</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-3940-9861</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talkowski</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2889-0992</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorger</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials><Identifier Source="ORCID">0000-0002-3364-1838</Identifier><AffiliationInfo><Affiliation>Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyman</LastName><ForeName>Bradley T</ForeName><Initials>BT</Initials><Identifier Source="ORCID">0000-0002-7959-9401</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albers</LastName><ForeName>Mark W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-7855-3455</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA. albers.mark@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG058063</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062421</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 OD006662</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005134</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS094861</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG058063</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM107618</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012330">RNA, Double-Stranded</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="Y">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012330" MajorTopicYN="N">RNA, Double-Stranded</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34233951</ArticleId><ArticleId IdType="mid">NIHMS1768798</ArticleId><ArticleId IdType="pmc">PMC8779652</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aaz4699</ArticleId><ArticleId IdType="pii">13/601/eaaz4699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA, Gene regulation and DNA damage in the ageing human brain. Nature 429, 883&#x2013;891 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15190254</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, Berkutzki T, Barnett-Itzhaki Z, Bezalel D, Wyss-Coray T, Amit I, Schwartz M, Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89&#x2013;93 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869326</ArticleId><ArticleId IdType="pubmed">25147279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu JH, Zhang H, Wagey R, Krieger C, Pelech SL, Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. Journal of Neurochemistry 85, 432&#x2013;442 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12675919</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, Muhammad AK, Ho R, Carmona S, Vit JP, Zarrow J, Kim KJ, Bell S, Harms MB, Miller TM, Dangler CA, Underhill DM, Goodridge HS, Lutz CM, Baloh RH, C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324&#x2013;1329 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JM, Minter MR, Newman AG, Zhang M, Adlard PA, Crack PJ, Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease. Neurobiology of aging 35, 1012&#x2013;1023 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24262201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Yang B, Zhang D, Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 59, 946&#x2013;958 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077460</ArticleId><ArticleId IdType="pubmed">21446050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Baglio F, Agostini S, Cabinio M, Lagana MM, Hernis A, Margaritella N, Guerini FR, Zanzottera M, Nemni R, Clerici M, Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment. Frontiers in aging neuroscience 6, 285 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197651</ArticleId><ArticleId IdType="pubmed">25360113</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckham JD, Pastula DM, Massey A, Tyler KL, Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus. JAMA neurology 73, 875&#x2013;879 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5087605</ArticleId><ArticleId IdType="pubmed">27183312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD, Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain : a journal of neurology 135, 736&#x2013;750 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 126, 829&#x2013;844 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu XD, Bennett CF, Cleveland DW, Ravits J, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proceedings of the National Academy of Sciences of the United States of America 110, E4530&#x2013;4539 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung DW, Basler CF, Amarasinghe GK, Molecular mechanisms of viral inhibitors of RIG-I-like receptors. Trends Microbiol 20, 139&#x2013;146 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299846</ArticleId><ArticleId IdType="pubmed">22325030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonin M, Oberstrass J, Lukacs N, Ewert K, Oesterschulze E, Kassing R, Nellen W, Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopy. RNA 6, 563&#x2013;570 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369937</ArticleId><ArticleId IdType="pubmed">10786847</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldi TK, Ash PE, Wilson G, Gonzales P, Garrido&#x2013;Lecca A, Roberts CM, Dostal V. Gendron TF, Stein LD, Blumenthal T, Petrucelli L, Link CD, TDP&#x2013;1, the Caenorhabditis elegans ortholog of TDP&#x2013;43, limits the accumulation of double&#x2013;stranded RNA. 33, 2947&#x2013;2966 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282642</ArticleId><ArticleId IdType="pubmed">25391662</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo CB, Erlandsen H, Mouser DJ, Feinstein AG, Robinson VL, May ER, Cole JL, Structural Basis of Protein Kinase R Autophosphorylation. Biochemistry 58, 2967&#x2013;2977 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6615999</ArticleId><ArticleId IdType="pubmed">31246429</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, Murray ME, Overstreet KK, Piazza-Johnston AE, Desaro P, Bieniek KF, DeTure M, Lee WC, Biendarra SM, Davis MD, Baker MC, Perkerson RB, van Blitterswijk M, Stetler CT, Rademakers R, Link CD, Dickson DW, Boylan KB, Li H, Petrucelli L, Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci 18, 1175&#x2013;1182 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma'ayan A, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH, Choi SH, D'Avanzo C, Hebisch M, Sliwinski C, Bylykbashi E, Washicosky KJ, Klee JB, Brustle O, Tanzi RE, Kim DY, A 3D human neural cell culture system for modeling Alzheimer's disease. Nature protocols 10, 985&#x2013;1006 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4499058</ArticleId><ArticleId IdType="pubmed">26068894</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Subramanian K, Berberich MJ, Rodriguez S, Latorre IJ, Luria CM, Everley R, Albers MW, Mitchison TJ, Sorger PK, A dynamic view of the proteomic landscape during differentiation of ReNcell VM cells, an immortalized human neural progenitor line. Sci Data 6, 190016 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380223</ArticleId><ArticleId IdType="pubmed">30778261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal VS, Zhang F, Yizhar O, Deisseroth K, Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698&#x2013;702 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3969859</ArticleId><ArticleId IdType="pubmed">19396159</ArticleId></ArticleIdList></Reference><Reference><Citation>Shykind BM, Rohani SC, O'Donnell S, Nemes A, Mendelsohn M, Sun Y, Axel R, Barnea G, Gene switching and the stability of odorant receptor gene choice. Cell 117, 801&#x2013;815 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15186780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogos JA, Osborne J, Nemes A, Mendelsohn M, Axel R, Genetic ablation and restoration of the olfactory topographic map. Cell 103, 609&#x2013;620 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11106731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscom C, Talkowski M, Design of large-insert jumping libraries for structural variant detection using illumina sequencing. Current protocols in human genetics / editorial board, Jonathan L. Haines &#x2026; [et al.] 80, 7 22 21&#x2013;29 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4009510</ArticleId><ArticleId IdType="pubmed">24789519</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L, Schrank BR, Rodriguez S, Benz EG, Moulia TW, Rickenbacher GT, Gomez AC, Levites Y, Edwards SR, Golde TE, Hyman BT, Barnea G, Albers MW, Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun 3, 1009 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529477</ArticleId><ArticleId IdType="pubmed">22910355</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleidi M, Hallett PJ, Koprich JB, Chung CY, Isacson O, The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience 30, 16091&#x2013;16101 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075577</ArticleId><ArticleId IdType="pubmed">21123556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantier MP, Williams BR, The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev 18, 363&#x2013;371 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084215</ArticleId><ArticleId IdType="pubmed">17698400</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LM, Keith AB, Davis S, Oakley AE, Edwardson JA, Morris CM, Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. Glia 44, 1&#x2013;12 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12951652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nallagatla SR, Toroney R, Bevilacqua PC, Regulation of innate immunity through RNA structure and the protein kinase PKR. Current opinion in structural biology 21, 119&#x2013;127 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075410</ArticleId><ArticleId IdType="pubmed">21145228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S, Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276&#x2013;289 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23273991</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S, Pattern recognition receptors and inflammation. Cell 140, 805&#x2013;820 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Brubaker SW, Gauthier AE, Mills EW, Ingolia NT, Kagan JC, A Bicistronic MAVS Transcript Highlights a Class of Truncated Variants in Antiviral Immunity. Cell 156, 800&#x2013;811 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959641</ArticleId><ArticleId IdType="pubmed">24529381</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanier C, Zemirli N, Portier A, Garcin D, Bidere N, Vazquez A, Arnoult D, MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors. BMC biology 10, 44 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372421</ArticleId><ArticleId IdType="pubmed">22626058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialas AR, Presumey J, Das A, Poel C. E. v. d., Lapchak PH, Mesin L, Victora G, Tsokos GC, Mawrin C, Herbst R, Carroll MC, Microglia-dependent synapse loss in type I interferon-mediated lupus. Nature, (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28614301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Zhu F, Cho YY, Tang F, Zykova T, Ma WY, Bode AM, Dong Z, Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 23, 121&#x2013;132 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2227311</ArticleId><ArticleId IdType="pubmed">16818236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Guo L, Gonzales PK, Gendron TF, Wu Y, Jansen-West K, O'Raw AD, Pickles SR, Prudencio M, Carlomagno Y, Gachechiladze MA, Ludwig C, Tian R, Chew J, DeTure M, Lin WL, Tong J, Daughrity LM, Yue M, Song Y, Andersen JW, Castanedes-Casey M, Kurti A, Datta A, Antognetti G, McCampbell A, Rademakers R, Oskarsson B, Dickson DW, Kampmann M, Ward ME, Fryer JD, Link CD, Shorter J, Petrucelli L, Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science 363, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook C, Petrucelli L, Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS. Neuron 101, 1057&#x2013;1069 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM, Castelli LM, Ferraiuolo L, Sanchez-Martinez A, Cooper-Knock J, Higginbottom A, Lin YH, Bauer CS, Dodd JE, Myszczynska MA, Alam SM, Garneret P, Chandran JS, Karyka E, Stopford MJ, Smith EF, Kirby J, Meyer K, Kaspar BK, Isaacs AM, El-Khamisy SF, De Vos KJ, Ning K, Azzouz M, Whitworth AJ, Shaw PJ, SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nature communications 8, 16063 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD, The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56&#x2013;61 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP, Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron 96, 285&#x2013;297 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Green KM, Glineburg MR, Kearse MG, Flores BN, Linsalata AE, Fedak SJ, Goldstrohm AC, Barmada SJ, Todd PK, RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat Commun 8, 2005 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldi TK, Gonzales PK, LaRocca TJ, Link CD, Neurodegeneration, Heterochromatin, and Double-Stranded RNA. Journal of Experimental Neuroscience 13, 1179069519830697 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376497</ArticleId><ArticleId IdType="pubmed">30792577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, Consortium NA, Fagegaltier D, Harris BT, Ostrow LW, Phatnani H, Ravits J, Dubnau J, Gale Hammell M, Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep 29, 1164&#x2013;1177 e1165 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TA, Smith BRC, Tate MD, Belz GT, Barrios MH, Elgass KD, Weisman AS, Baker PJ, Preston SP, Whitehead L, Garnham A, Lundie RJ, Smyth GK, Pellegrini M, O'Keeffe M, Wicks IP, Masters SL, Hunter CP, Pang KC, SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition. Immunity 47, 498&#x2013;509 e496 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679266</ArticleId><ArticleId IdType="pubmed">28916264</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Chen J, Xu H, Liu S, Jiang QX, Halfmann R, Chen ZJ, Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207&#x2013;1222 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034535</ArticleId><ArticleId IdType="pubmed">24630723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ, MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448&#x2013;461 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179916</ArticleId><ArticleId IdType="pubmed">21782231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, Sherman MA, Vitzthum CM, Luquette LJ, Yandava C, Yang P, Chittenden TW, Hatem NE, Ryu SC, Woodworth MB, Park PJ, Walsh CA, Aging and neurodegeneration are associated with increased mutations in single human neurons. Science, (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29976800</ArticleId></ArticleIdList></Reference><Reference><Citation>Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, Gyorgy B, Breakefield XO, Tanzi RE, Moir RD, Alzheimer's Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron 99, 56&#x2013;63 e53 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075814</ArticleId><ArticleId IdType="pubmed">30001512</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B, Haure-Mirande J-V, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, Reiman EM, Schadt EE, Ehrlich ME, Gandy S, Dudley JT, Multiscale Analysis of Independent Alzheimer&#x2019;s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551233</ArticleId><ArticleId IdType="pubmed">29937276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H, Calis JJA, Wu X, Sun T, Yu Y, Sarbanes SL, Dao Thi VL, Shilvock AR, Hoffmann HH, Rosenberg BR, Rice CM, Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831367</ArticleId><ArticleId IdType="pubmed">29395325</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, Suzuki-Uematsu S, Ghosh S, Singh A, Merkle FT, Koszka K, Li QZ, Zon L, Rossi DJ, Trowbridge JJ, Notarangelo LD, Eggan K, Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8, 347ra393 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, Diaz Garcia S, Ghosh Dastidar S, Rodriguez MJ, King P, Zhang Y, La Spada AR, Xu H, Petrucelli L, Ravits J, Da Cruz S, Lagier-Tourenne C, Cleveland DW, Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci 23, 615&#x2013;624 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, Petersen RC, Dickson DW, Staging TDP-43 pathology in Alzheimer's disease. Acta neuropathologica 127, 441&#x2013;450 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944799</ArticleId><ArticleId IdType="pubmed">24240737</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CR Jr., Parisi JE, Petersen RC, Dickson DW, TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta neuropathologica 127, 811&#x2013;824 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez S, Sickles HM, Deleonardis C, Alcaraz A, Gridley T, Lin DM, Notch2 is required for maintaining sustentacular cell function in the adult mouse main olfactory epithelium. Dev Biol 314, 40&#x2013;58 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2374763</ArticleId><ArticleId IdType="pubmed">18155189</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L, Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28, 511&#x2013;515 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146043</ArticleId><ArticleId IdType="pubmed">20436464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma'ayan A, Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44, W90&#x2013;97 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai L, Barnea G, A critical period defined by axon-targeting mechanisms in the murine olfactory bulb. Science 344, 197&#x2013;200 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4104295</ArticleId><ArticleId IdType="pubmed">24723611</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D'Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, Klee JB, Zhang C, Wainger BJ, Peitz M, Kovacs DM, Woolf CJ, Wagner SL, Tanzi RE, Kim DY, A three-dimensional human neural cell culture model of Alzheimer's disease. Nature, (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>